Join
Live feed
·
PRReleasevia Quantisnow
Abbott Laboratories logo

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

ByQuantisnow·Wall Street's wire, on your screen.
ABT· Abbott Laboratories
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABT (Abbott Laboratories) and more on Quantisnow.